Poor diagnostic performance of tilt testing in hypertensive patients with unexplained syncope

Journal of Human Hypertension

Volumn 28, Issue 4, 2014, Pages 259-262

  Ungar, A ^a,b   Rafanelli, M ^a,b   Cellai, T ^a,b   Ceccofiglio, A ^a,b   Del Rosso, A ^c   Mussi, C ^d   Marchionni, N ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c SAN GIUSEPPE HOSPITAL   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

nitroglycerin; syncope; tilt testing

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLYCERYL TRINITRATE; VASODILATOR AGENT;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CHILD; CONTROLLED STUDY; DRUG SPECIFICITY; DRUG TOLERABILITY; FAINTNESS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; SCHOOL CHILD; TILT TABLE TEST; VERY ELDERLY; YOUNG ADULT; AGE; AUTONOMIC NERVOUS SYSTEM; CASE CONTROL STUDY; DIAGNOSTIC USE; ELECTROCARDIOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SUBLINGUAL DRUG ADMINISTRATION; SYNCOPE;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM; CASE-CONTROL STUDIES; CHILD; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITROGLYCERIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYNCOPE; TILT-TABLE TEST; VASODILATOR AGENTS; YOUNG ADULT;

EID: 84896317584     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.95     Document Type: Article

References (27)

1. Savage DD, Corwin L, McGee DL, Kannel WB, Wolf PA. Epidemiological features of isolated syncope: the Framingham Study. Stroke 1985; 16: 626-629.
2. Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol 1991; 44: 1037-1043.
3. Brignole M, Disertori M, Menozzi C, Raviele A, Alboni P, Pitzalis MV et al. Evaluation of guidelines in Syncope Study group. Europace 2003; 5: 293-298.
4. Ungar A, Galizia G, Morrione A, Mussi C, Noro G, Ghirelli L et al. Two-year morbidity and mortality in elderly patients with syncope. Age Ageing 2011; 40: 696-702.
5. Raviele A, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995; 76: 267-272.
6. Del Rosso A, Bartoli P, Bartoletti A, Brandinelli-Geri A, Bonechi F, Maioli M et al. Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am Heart J 1998; 135: 564-570.
7. Del Rosso A, Ungar A, Bartoli P, Cellai T, Mussi C, Marchionni N et al. Usefulness and safety of shortened head-up tilt testing potentiated with sublingual glyceril trinitrate in older patients with recurrent unexplained syncope. JAGS 2002; 50: 1324-1328.
8. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB et al. Task Force for the Diagnosis and Management of Syncope, European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS). Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009; 30: 2631-2671.
9. Bartoletti A, Alboni P, Ammirati F, Brignole M, Del Rosso A, Foglia MG et al. The tilt test enhanced with oral nitroglycerin in patients with unexplained syncope: the Italian Protocol. The Working Group on Syncope of the Associazione Italiana di Aritmologia e Cardiostimolazione-the Arrhythmia Area of the qAssociazione Nazionale Medici Cardiologi Ospedalieri. Ital Heart J Suppl 2000; 1: 226-231.
10. Friedman DB, Jensen FB, Matzen S, Secher NH. Non-invasive blood pressure monitoring during head-up tilt using the Penaz principle. Acta Anesthesiol Scand 1990; 34: 519-522.
11. Malik M, Farrel TG, Camm AJ. Evaluation of receiver operator characteristics: optimal time of day for assessment of heart rate variability after acute myocardial infarction. Int J Biomed Comput 1991; 27: 175-192.
12. Natale A, Akhtar M, Jazayeri M, Dhala A, Blanck Z, Deshpande S et al. Provocation of hypotension during head-up tilt testing in subjects with non history of syncope or presyncope. Circulation 1995; 92: 54-58.
13. Brignole M, Menozzi C, Del Rosso A, Costa S, Gaggioli G, Bottoni N et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. Europace 2000; 2: 66-76.
14. Del Rosso A, Bartoletti A, Bartoli P, Ungar A, Bonechi F, Maioli M et al. Methodology of head-up tilt testing potentiated with sublingual nitroglycerin in unexplained syncope. Am J Cardiol 2000; 85: 1007-1011.
15. Brignole M, Menozzi C, Bartoletti A, Giada F, Lagi A, Ungar A et al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J 2006; 27: 7-9.
16. Dandona P, James IM, Newbury PA, Woollard ML, Beckett AG. Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebral vascular reactivity. Br Med J 1978; 2: 325-326.
17. Barón-Esquivias G, Gómez S, Cayuela A, Valle JI, Pedrote A, Mart́inez A et al. Analysis of head-up tilt test responses in patients suffering from syncope and high blood pressure. Rev Esp Cardiol 2006; 59: 68-71.
18. Pugliatti P, Patanè S, Recupero A, Coglitore S, Di Bella G. Pharmacological washout for the correct evaluation of the head-up tilt testing. Int J Cardiol 2008; 127: e31-e32.
19. Biffi M, Boriani G, Sabbatini P, Bronzetti G, Frabetti L, Zannoli R et al. Malignant vasovagal syncope: a randomized trial of metoprolol and clonidin. Heart 1997; 77: 68-272.
20. Cohen MB, Snow JS, Grasso V, Lehnert L, Goldner BG, Jadonath RL et al. Efficacy of pindolol for treatment of vasovagal syncope. Am Heart J 1995; 130: 786-790.
21. Muller G, Deal B, Strasburger JF, Benson Jr. DW. Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Am J Cardiol 1993; 71: 592-595.
22. Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992; 70: 339-342.
23. Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006; 113: 1164-1170.
24. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996; 78: 536-539.
25. Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sanchez A et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001; 37: 554-559.
26. Zeng C, Zhu Z, Liu G, Hu W, Wang X, Yang C et al. Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope. Am Heart J 1998; 136: 852-858.
27. Esler M, Rumantir M, Kaye D, Lambert G. The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction? Am J Hypertens 2001; 14: 139-146.